• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Korean Med Sci . Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series

tetano

Editor, Senior Moderator
J Korean Med Sci


. 2023 Mar 27;38(12):e95.
doi: 10.3346/jkms.2023.38.e95.
Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series


Yeji Moon[SUP] 1 [/SUP], Jae Ho Jung[SUP] 2 [/SUP], Hyun Jin Shin[SUP] 3 [/SUP], Dong Gyu Choi[SUP] 4 [/SUP], Kyung-Ah Park[SUP] 5 [/SUP], Hyeshin Jeon[SUP] 6 [/SUP], Byung Joo Lee[SUP] 1 [/SUP], Seong-Joon Kim[SUP] 7 [/SUP], Sei Yeul Oh[SUP] 5 [/SUP], Hyosook Ahn[SUP] 1 [/SUP], Seung Ah Chung[SUP] 8 [/SUP], Ungsoo Samuel Kim[SUP] 9 [/SUP], Haeng-Jin Lee[SUP] 10 [/SUP], Joo Yeon Lee[SUP] 11 [/SUP], Youn Joo Choi[SUP] 12 [/SUP]; Korean Neuro-Ophthalmology Society



Affiliations

Abstract

Background: To report the clinical manifestations of non-arteritic anterior ischemic optic neuropathy (NAION) cases after coronavirus disease 2019 (COVID-19) vaccination in Korea.
Methods: This multicenter retrospective study included patients diagnosed with NAION within 42 days of COVID-19 vaccination. We collected data on vaccinations, demographic features, presence of vascular risk factors, ocular findings, and visual outcomes of patients with NAION.
Results: The study included 16 eyes of 14 patients (6 men, 8 women) with a mean age of 63.5 ± 9.1 (range, 43-77) years. The most common underlying disease was hypertension, accounting for 28.6% of patients with NAION. Seven patients (50.0%) had no vascular risk factors for NAION. The mean time from vaccination to onset was 13.8 ± 14.2 (range, 1-41) days. All 16 eyes had disc swelling at initial presentation, and 3 of them (18.8%) had peripapillary intraretinal and/or subretinal fluid with severe disc swelling. Peripapillary hemorrhage was found in 50% of the patients, and one (6.3%) patient had peripapillary cotton-wool spots. In eight fellow eyes for which we were able to review the fundus photographs, the horizontal cup/disc ratio was less than 0.25 in four eyes (50.0%). The mean visual acuity was logMAR 0.6 ± 0.7 at the initial presentation and logMAR 0.7 ± 0.8 at the final visit.
Conclusion: Only 64% of patients with NAION after COVID-19 vaccination have known vascular and ocular risk factors relevant to ischemic optic neuropathy. This suggests that COVID-19 vaccination may increase the risk of NAION. However, overall clinical features and visual outcomes of the NAION patients after COVID-19 vaccination were similar to those of typical NAION.

Keywords: Coronavirus Disease 2019 (COVID-19); Non-Arteritic Anterior Ischemic Optic Neuropathy; Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); Vaccination.
 
Back
Top Bottom